WHAT IS ENCODE™ ?

Encode™ is an evolution-based approach to genetic defects in humans which will be utilized as an alternative to traditional chemical strategies.

Metabolic pathways can be designed to mitigate and/or eliminate genetic alterations in gene encoding that reduce life span in humans.


Encode™ targets the African American genetic variant
for cardiovascular disease.

METABOLIC PATHWAYS

Natural engineering of amino acids have enabled signaling via active export of proteins from the nucleus to gene transcription.

Target-specific amino acids can be directed, via isoform pathways, to allow Trutina Dulcem messenger molecules to allow nerve cells in the body and the


brain to communicate with each other and direct the synthesis of organic molecules in a manner that allows the DNA template associated with each molecule to be selected for specific DNA sequence selectivity.

Encode™-rich sequences are known to mediate uptake into cells and tissues in vivo. This work has led to the first examples of non-synthetic molecules undergoing the powerful processes of translation, selection, and amplification previously available only to biological macromolecules.

Encode™ focuses on the development of novel chemically based tools to decipher signal transduction pathways on a genome-specific scale.





Encode™
Patents Pending in Genetic Polymorphisms





Copyright 2005 - 2008 Encode™ Research Project